These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21520023)

  • 1. A new direction for anticoagulants: inhibiting fibrin assembly with PEGylated fibrin knob mimics.
    Stabenfeldt SE; Aboujamous NM; Soon AS; Barker TH
    Biotechnol Bioeng; 2011 Oct; 108(10):2424-33. PubMed ID: 21520023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of fibrin matrix properties via knob:hole affinity interactions using peptide-PEG conjugates.
    Soon AS; Lee CS; Barker TH
    Biomaterials; 2011 Jul; 32(19):4406-14. PubMed ID: 21435714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interference of fibrin's divalent polymerization mechanism enables modulation of multiscale material properties.
    Brown AC; Baker SR; Douglas AM; Keating M; Alvarez-Elizondo MB; Botvinick EL; Guthold M; Barker TH
    Biomaterials; 2015 May; 49():27-36. PubMed ID: 25725552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters.
    Ulbricht K; Bucha E; Pöschel KA; Stein G; Wolf G; Nowak G
    Clin Nephrol; 2006 Mar; 65(3):180-90. PubMed ID: 16550749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Primary Polymerization of Fibrin by Blood Anticoagulant System Components.
    Lyapina LA; Maistrenko ES
    Bull Exp Biol Med; 2017 May; 163(1):46-48. PubMed ID: 28580517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of fibrinogen with poly(ethylene glycol) and its effects on fibrin clot characteristics.
    Barker TH; Fuller GM; Klinger MM; Feldman DS; Hagood JS
    J Biomed Mater Res; 2001 Sep; 56(4):529-35. PubMed ID: 11400130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-derivatized albumins that inhibit fibrin polymerization.
    Watson JW; Doolittle RF
    Biochemistry; 2011 Nov; 50(45):9923-7. PubMed ID: 22010909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-fibrin conjugates: the PEG impact on the polymerization dynamics.
    Bakulina AA; Musina GR; Gavdush AA; Efremov YM; Komandin GA; Vosough M; Shpichka AI; Zaytsev KI; Timashev PS
    Soft Matter; 2023 Mar; 19(13):2430-2437. PubMed ID: 36930054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building better fibrin knob mimics: an investigation of synthetic fibrin knob peptide structures in solution and their dynamic binding with fibrinogen/fibrin holes.
    Stabenfeldt SE; Gossett JJ; Barker TH
    Blood; 2010 Aug; 116(8):1352-9. PubMed ID: 20484082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering fibrin polymers through engagement of alternative polymerization mechanisms.
    Stabenfeldt SE; Gourley M; Krishnan L; Hoying JB; Barker TH
    Biomaterials; 2012 Jan; 33(2):535-44. PubMed ID: 22018389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels.
    Welsch N; Brown AC; Barker TH; Lyon LA
    Colloids Surf B Biointerfaces; 2018 Jun; 166():89-97. PubMed ID: 29549720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide.
    Hagemeyer CE; Tomic I; Jaminet P; Weirich U; Bassler N; Schwarz M; Runge MS; Bode C; Peter K
    Thromb Haemost; 2004 Jul; 92(1):47-53. PubMed ID: 15213844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
    Bompiani KM; Monroe DM; Church FC; Sullenger BA
    J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen C-terminal peptidic sequences (Haptides) modulate fibrin polymerization.
    Marx G; Ben-Moshe M; Magdassi S; Gorodetsky R
    Thromb Haemost; 2004 Jan; 91(1):43-51. PubMed ID: 14691567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers.
    Moreno A; Pitoc GA; Ganson NJ; Layzer JM; Hershfield MS; Tarantal AF; Sullenger BA
    Cell Chem Biol; 2019 May; 26(5):634-644.e3. PubMed ID: 30827937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From
    Farkas ÁZ; Farkas VJ; Szabó L; Wacha A; Bóta A; Csehi L; Kolev K; Thelwell C
    Front Immunol; 2019; 10():2967. PubMed ID: 31921206
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin inhibitors based on single-stranded DNA aptamers.
    Gribkova IV; Spiridonova VA; Gorbatenko AS; Denisov SS; Ataullakhanov FI; Sinauridze EI
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):39-45. PubMed ID: 24247320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant mechanism of sulfonated polyisoprenes.
    Tamada Y; Murata M; Hayashi T; Goto K
    Biomaterials; 2002 Mar; 23(5):1375-82. PubMed ID: 11804293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic and chemical synthesis of new anticoagulant peptides.
    Origone A; Bersi G; Illanes A; Sturniolo H; Liggieri C; Guzmán F; Barberis S
    Biotechnol Prog; 2018 Sep; 34(5):1093-1101. PubMed ID: 29882241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual surface modification with PEG and corn trypsin inhibitor: effect of PEG:CTI ratio on protein resistance and anticoagulant properties.
    Alibeik S; Zhu S; Yau JW; Weitz JI; Brash JL
    J Biomed Mater Res A; 2012 Apr; 100(4):856-62. PubMed ID: 22241533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.